MilliporeSigma - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH2457D
- Pages: 56
- October 2018
- Total Views:1199
- Region : North America
- GlobalData
- Equity Research Report
Details
Summary
MilliporeSigma, formerly Sigma-Aldrich Corp, a subsidiary of Merck KGaA is a life sciences and technology company which offers biochemical and organic chemical products, kits and services. Its products and services find application in scientific research including genomic and proteomic research; diagnosis of diseases; pharmaceutical development and biotechnology sectors. The company offers its solutions to hospitals, biotechnology and pharmaceutical companies, commercial laboratories, universities, industrial companies, governmental institutions, non-profit organizations, diagnostic, and chemical and electronics companies. It operates across the Americas, Asia-Pacific, Europe, the Middle East and Africa. MilliporeSigma is headquartered in St. Louis, Missouri, the US.
MilliporeSigma-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MilliporeSigma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10
MilliporeSigma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MilliporeSigma, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
MilliporeSigma to Enter into Agreement with Samsung Biologics 13
MilliporeSigma Enters into Agreement with Angiex 14
F. Hoffmann-La Roche Expands its Distribution Agreement with MilliporeSigma 15
Sigma-Aldrich Enters into Agreement with Sanger Institute 16
Sigma-Aldrich Enters into Distribution Agreement with IROA Technologies 17
Sigma-Aldrich Enters into Distribution Agreement with Roche 18
BioSilta Enters into Co-Marketing Agreement with Sigma-Aldrich 19
Sigma-Aldrich Enters Into Distribution Agreement With Paragon Scientific 20
Sigma Life Science Enters Into Distribution Agreement With The Culture Collections of Public Health England 21
AB Sciex Enters Into Distribution Agreement With Sigma-Aldrich For Sciex Ichemistry Solutions 22
Sigma Life Science Expands Agreement With Autism Speaks To Develop Rat Models For Autism Research 23
Sigma Life Science Enters Into Co-Marketing Agreement With Axiogenesis 24
Genovis Enters Into Distribution Agreement With Sigma-Aldrich 25
TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 26
Licensing Agreements 27
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 27
Sage Labs Enters Into Licensing Agreement With Caribou Biosciences 28
Sigma-Aldrich Enters Into Licensing Agreement With Horizon Discovery For CompoZr Zinc Finger Nuclease Technology 29
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 30
Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 31
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 32
Materia Extends Licensing Agreement With Sigma Aldrich 33
Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 34
Sigma Life Science Enters Into Licensing Agreement With Kyoto University 35
Asset Transactions 36
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 36
Acquisition 38
Merck Acquires Sigma-Aldrich for USD17 Billion 38
Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 40
Sigma-Aldrich Acquires Research Organics, Manufacturer Of Biochemicals 41
MilliporeSigma-Key Competitors 42
MilliporeSigma-Key Employees 43
MilliporeSigma-Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 44
Recent Developments 45
Strategy And Business Planning 45
Oct 11, 2017: MilliporeSigma Opens New Life Science Center in Massachusetts for Scientific Collaboration 45
Sep 21, 2017: MilliporeSigma Opens Chinas First BioReliance End-to-End Biodevelopment Center in Shanghai 47
May 12, 2017: MilliporeSigma and Stelis Biopharma Open First Joint Bioprocess Scale-up Lab in India 48
Jan 10, 2017: MilliporeSigma Expands End-to-End Biodevelopment Centers in North America, China and Europe 49
Product News 50
May 17, 2017: MilliporeSigma Develops Alternative CRISPR Genome Editing Method 50
May 16, 2017: MilliporeSigma's CHOZN Expression System Selected for Bi-specific Antibody Development by SystImmune 51
May 01, 2017: MilliporeSigma's Mobius 2,000-liter Single-use Bioreactors to Expand Avid Bioservices' Manufacturing Capabilities 52
Feb 13, 2018: Merck Launches Viresolve Barrier Capsule Filters to Protect Against Bioreactor Contamination 53
Other Significant Developments 54
Oct 08, 2018: MilliporeSigma's novel chemiflex raw materials program solves regulatory compliance challenges in small molecule drug manufacturing 54
Sep 25, 2017: Avid Bioservices Expands Manufacturing Capabilities With Installation and Validation of Two MilliporeSigma Mobius 2,000-Liter Single-Use Bioreactors in Its Myford Facility 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
List Of Figure
List of Figures
MilliporeSigma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MilliporeSigma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
MilliporeSigma, Pharmaceuticals & Healthcare, Key Facts 2
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MilliporeSigma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MilliporeSigma, Deals By Therapy Area, 2012 to YTD 2018 9
MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10
MilliporeSigma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MilliporeSigma to Enter into Agreement with Samsung Biologics 13
MilliporeSigma Enters into Agreement with Angiex 14
F. Hoffmann-La Roche Expands its Distribution Agreement with MilliporeSigma 15
Sigma-Aldrich Enters into Agreement with Sanger Institute 16
Sigma-Aldrich Enters into Distribution Agreement with IROA Technologies 17
Sigma-Aldrich Enters into Distribution Agreement with Roche 18
BioSilta Enters into Co-Marketing Agreement with Sigma-Aldrich 19
Sigma-Aldrich Enters Into Distribution Agreement With Paragon Scientific 20
Sigma Life Science Enters Into Distribution Agreement With The Culture Collections of Public Health England 21
AB Sciex Enters Into Distribution Agreement With Sigma-Aldrich For Sciex Ichemistry Solutions 22
Sigma Life Science Expands Agreement With Autism Speaks To Develop Rat Models For Autism Research 23
Sigma Life Science Enters Into Co-Marketing Agreement With Axiogenesis 24
Genovis Enters Into Distribution Agreement With Sigma-Aldrich 25
TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 26
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 27
Sage Labs Enters Into Licensing Agreement With Caribou Biosciences 28
Sigma-Aldrich Enters Into Licensing Agreement With Horizon Discovery For CompoZr Zinc Finger Nuclease Technology 29
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 30
Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 31
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 32
Materia Extends Licensing Agreement With Sigma Aldrich 33
Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 34
Sigma Life Science Enters Into Licensing Agreement With Kyoto University 35
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 36
Merck Acquires Sigma-Aldrich for USD17 Billion 38
Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 40
Sigma-Aldrich Acquires Research Organics, Manufacturer Of Biochemicals 41
MilliporeSigma, Key Competitors 42
MilliporeSigma, Key Employees 43
MilliporeSigma, Subsidiaries 44
MilliporeSigma, Joint Venture 44
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
MilliporeSigma, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
MilliporeSigma, formerly Sigma-Aldrich Corp, a subsidiary of Merck KGaA is a life sciences and technology company which offers biochemical and organic chemical products, kits and services. Its products and services find application in scientific research including genomic and proteomic research; diagnosis of diseases; pharmaceutical development and biotechnology sectors. The company offers its solutions to hospitals, biotechnology and pharmaceutical companies, commercial laboratories, universities, industrial companies, governmental institutions, non-profit organizations, diagnostic, and chemical and electronics companies. It operates across the Americas, Asia-Pacific, Europe, the Middle East and Africa. MilliporeSigma is headquartered in St. Louis, Missouri, the US.
MilliporeSigma-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MilliporeSigma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10
MilliporeSigma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MilliporeSigma, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
MilliporeSigma to Enter into Agreement with Samsung Biologics 13
MilliporeSigma Enters into Agreement with Angiex 14
F. Hoffmann-La Roche Expands its Distribution Agreement with MilliporeSigma 15
Sigma-Aldrich Enters into Agreement with Sanger Institute 16
Sigma-Aldrich Enters into Distribution Agreement with IROA Technologies 17
Sigma-Aldrich Enters into Distribution Agreement with Roche 18
BioSilta Enters into Co-Marketing Agreement with Sigma-Aldrich 19
Sigma-Aldrich Enters Into Distribution Agreement With Paragon Scientific 20
Sigma Life Science Enters Into Distribution Agreement With The Culture Collections of Public Health England 21
AB Sciex Enters Into Distribution Agreement With Sigma-Aldrich For Sciex Ichemistry Solutions 22
Sigma Life Science Expands Agreement With Autism Speaks To Develop Rat Models For Autism Research 23
Sigma Life Science Enters Into Co-Marketing Agreement With Axiogenesis 24
Genovis Enters Into Distribution Agreement With Sigma-Aldrich 25
TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 26
Licensing Agreements 27
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 27
Sage Labs Enters Into Licensing Agreement With Caribou Biosciences 28
Sigma-Aldrich Enters Into Licensing Agreement With Horizon Discovery For CompoZr Zinc Finger Nuclease Technology 29
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 30
Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 31
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 32
Materia Extends Licensing Agreement With Sigma Aldrich 33
Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 34
Sigma Life Science Enters Into Licensing Agreement With Kyoto University 35
Asset Transactions 36
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 36
Acquisition 38
Merck Acquires Sigma-Aldrich for USD17 Billion 38
Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 40
Sigma-Aldrich Acquires Research Organics, Manufacturer Of Biochemicals 41
MilliporeSigma-Key Competitors 42
MilliporeSigma-Key Employees 43
MilliporeSigma-Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 44
Recent Developments 45
Strategy And Business Planning 45
Oct 11, 2017: MilliporeSigma Opens New Life Science Center in Massachusetts for Scientific Collaboration 45
Sep 21, 2017: MilliporeSigma Opens Chinas First BioReliance End-to-End Biodevelopment Center in Shanghai 47
May 12, 2017: MilliporeSigma and Stelis Biopharma Open First Joint Bioprocess Scale-up Lab in India 48
Jan 10, 2017: MilliporeSigma Expands End-to-End Biodevelopment Centers in North America, China and Europe 49
Product News 50
May 17, 2017: MilliporeSigma Develops Alternative CRISPR Genome Editing Method 50
May 16, 2017: MilliporeSigma's CHOZN Expression System Selected for Bi-specific Antibody Development by SystImmune 51
May 01, 2017: MilliporeSigma's Mobius 2,000-liter Single-use Bioreactors to Expand Avid Bioservices' Manufacturing Capabilities 52
Feb 13, 2018: Merck Launches Viresolve Barrier Capsule Filters to Protect Against Bioreactor Contamination 53
Other Significant Developments 54
Oct 08, 2018: MilliporeSigma's novel chemiflex raw materials program solves regulatory compliance challenges in small molecule drug manufacturing 54
Sep 25, 2017: Avid Bioservices Expands Manufacturing Capabilities With Installation and Validation of Two MilliporeSigma Mobius 2,000-Liter Single-Use Bioreactors in Its Myford Facility 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
List Of Figure
List of Figures
MilliporeSigma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MilliporeSigma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
MilliporeSigma, Pharmaceuticals & Healthcare, Key Facts 2
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MilliporeSigma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
MilliporeSigma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MilliporeSigma, Deals By Therapy Area, 2012 to YTD 2018 9
MilliporeSigma, Medical Devices Deals, 2012 to YTD 2018 10
MilliporeSigma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MilliporeSigma to Enter into Agreement with Samsung Biologics 13
MilliporeSigma Enters into Agreement with Angiex 14
F. Hoffmann-La Roche Expands its Distribution Agreement with MilliporeSigma 15
Sigma-Aldrich Enters into Agreement with Sanger Institute 16
Sigma-Aldrich Enters into Distribution Agreement with IROA Technologies 17
Sigma-Aldrich Enters into Distribution Agreement with Roche 18
BioSilta Enters into Co-Marketing Agreement with Sigma-Aldrich 19
Sigma-Aldrich Enters Into Distribution Agreement With Paragon Scientific 20
Sigma Life Science Enters Into Distribution Agreement With The Culture Collections of Public Health England 21
AB Sciex Enters Into Distribution Agreement With Sigma-Aldrich For Sciex Ichemistry Solutions 22
Sigma Life Science Expands Agreement With Autism Speaks To Develop Rat Models For Autism Research 23
Sigma Life Science Enters Into Co-Marketing Agreement With Axiogenesis 24
Genovis Enters Into Distribution Agreement With Sigma-Aldrich 25
TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 26
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 27
Sage Labs Enters Into Licensing Agreement With Caribou Biosciences 28
Sigma-Aldrich Enters Into Licensing Agreement With Horizon Discovery For CompoZr Zinc Finger Nuclease Technology 29
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 30
Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 31
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 32
Materia Extends Licensing Agreement With Sigma Aldrich 33
Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 34
Sigma Life Science Enters Into Licensing Agreement With Kyoto University 35
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 36
Merck Acquires Sigma-Aldrich for USD17 Billion 38
Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 40
Sigma-Aldrich Acquires Research Organics, Manufacturer Of Biochemicals 41
MilliporeSigma, Key Competitors 42
MilliporeSigma, Key Employees 43
MilliporeSigma, Subsidiaries 44
MilliporeSigma, Joint Venture 44
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
MilliporeSigma, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
March 2021
Page 140 | November 2020
Page 99 | July 2020
Page 75 | July 2020
Page 114 | May 2020